AAAAAA

   
Results: 1-11 |
Results: 11
THE ROLE OF ECONOMIC-EVALUATION IN THE PRICING AND REIMBURSEMENT OF MEDICINES
Authors: DRUMMOND M JONSSON B RUTTEN F
Citation: M. Drummond et al., THE ROLE OF ECONOMIC-EVALUATION IN THE PRICING AND REIMBURSEMENT OF MEDICINES, Health policy, 40(3), 1997, pp. 199-215
ECONOMIC-EVALUATION AND HEALTH-CARE DECISION-MAKING
Authors: RUTTEN F
Citation: F. Rutten, ECONOMIC-EVALUATION AND HEALTH-CARE DECISION-MAKING, Health policy, 36(3), 1996, pp. 215-229
METHODS CONTROVERSIES AND AGREEMENT - ASSESSING QUALITY AND COST
Authors: TORRANCE G MAGAT W GAFNI A RUTTEN F
Citation: G. Torrance et al., METHODS CONTROVERSIES AND AGREEMENT - ASSESSING QUALITY AND COST, Medical care, 34(12), 1996, pp. 69-74
STANDARDS DEVELOPMENT - EUROPE
Authors: ROVIRA J LOVATT B RUTTEN F
Citation: J. Rovira et al., STANDARDS DEVELOPMENT - EUROPE, Medical care, 34(12), 1996, pp. 189-190
ECONOMIC APPRAISAL AND HEALTH TECHNOLOGY POLICY - INTRODUCTION
Authors: DRUMMOND M DAVIES L RUTTEN F
Citation: M. Drummond et al., ECONOMIC APPRAISAL AND HEALTH TECHNOLOGY POLICY - INTRODUCTION, Social science & medicine, 38(12), 1994, pp. 1591-1592
INTEGRATION OF ECONOMIC APPRAISAL AND HEALTH-CARE POLICY IN A HEALTH-INSURANCE SYSTEM - THE DUTCH CASE
Authors: RUTTEN F VANDERLINDEN JW
Citation: F. Rutten et Jw. Vanderlinden, INTEGRATION OF ECONOMIC APPRAISAL AND HEALTH-CARE POLICY IN A HEALTH-INSURANCE SYSTEM - THE DUTCH CASE, Social science & medicine, 38(12), 1994, pp. 1609-1614
EXPLAINING COST VARIATIONS IN DRGS ACUTE MYOCARDIAL-INFARCTION BY SEVERITY OF ILLNESS
Authors: VOSS GBWE HASMAN A RUTTEN F DEZWAAN C CARPAY JJ
Citation: Gbwe. Voss et al., EXPLAINING COST VARIATIONS IN DRGS ACUTE MYOCARDIAL-INFARCTION BY SEVERITY OF ILLNESS, Health policy, 28(1), 1994, pp. 37-50
WILMS-TUMOR SUPPRESSOR GENE-EXPRESSION IN RAT AND HUMAN MESOTHELIOMA
Authors: WALKER C RUTTEN F YUAN XQ PASS H MEW DM EVERITT J
Citation: C. Walker et al., WILMS-TUMOR SUPPRESSOR GENE-EXPRESSION IN RAT AND HUMAN MESOTHELIOMA, Cancer research, 54(12), 1994, pp. 3101-3106
A MULTINATIONAL PHARMACOECONOMIC ANALYSIS OF ORAL THERAPIES FOR ONYCHOMYCOSIS
Authors: ARIKIAN SR EINARSON TR KOBELTNGUYEN G SCHUBERT F ALLEN R BARAN R BERGMAN W BITETTO L BLATTSTEIN JS BREDA M CLEMENT W DECUYPER C DIFONZO E VANDOORSLAER E DOYLE JJ EFFENDY I EICHMANN A FEUILHADE M FIGUEIREDO A FLORI YA",GERMAINE,"CAMARASA JMG GINTER G GISBERT R GOODFIELD M GROENEWEG DA GUNN D HANNUKSELA M HAVU V KNAPPE E KOUSSIDOUEREMONTI T LATEUR N LEE RE LUCIONI C MATHIOUDAKI E MIKULITS R NOLTING S PANAGIOTIDOU D PEKURINEN M PEREIRA J REY JP PIETRINI P SOARES AP PIRARD C ROBERTS DT ROVIRA J RUFLI T RUTTEN F SOMMER JH SPANGLER E STARY A STAVRIANEAS N STAVROPOULOS P STUBB S TADDIO A TOPOLEWSKI K TOSTI A YFANTOPOULOS J VAGENA A VANHECKE E VARELTZIDIS A ZALINSKI J
Citation: Sr. Arikian et al., A MULTINATIONAL PHARMACOECONOMIC ANALYSIS OF ORAL THERAPIES FOR ONYCHOMYCOSIS, British journal of dermatology, 130, 1994, pp. 35-44
ECONOMIC-EVALUATION OF PHARMACEUTICALS - A EUROPEAN PERSPECTIVE
Authors: DRUMMOND M RUTTEN F BRENNA A PINTO CG HORISBERGER B JONSSON B LEPEN C ROVIRA J VONDERSCHULENBURG MG SINTONEN H TORFS K
Citation: M. Drummond et al., ECONOMIC-EVALUATION OF PHARMACEUTICALS - A EUROPEAN PERSPECTIVE, PharmacoEconomics, 4(3), 1993, pp. 173-186
SYSTEM SCIENCE IN HEALTH-CARE - INTRODUCTION
Authors: CULYER AJ HORISBERGER B JONSON B RUTTEN F
Citation: Aj. Culyer et al., SYSTEM SCIENCE IN HEALTH-CARE - INTRODUCTION, European journal of cancer, 29A, 1993, pp. 1-2
Risultati: 1-11 |